Becton, Dickinson and Co.  

(Public, NYSE:BDX)   Watch this stock  
Find more results for BDX
+1.53 (1.02%)
Real-time:   2:01PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 149.61 - 151.47
52 week 112.15 - 151.47
Open 149.99
Vol / Avg. 723,943.00/941,174.00
Mkt cap 31.45B
P/E 27.74
Div/yield 0.60/1.58
EPS 5.46
Shares 209.39M
Beta 0.89
Inst. own 85%
Aug 6, 2015
Q3 2015 Becton, Dickinson and Co Earnings Release - 9:30AM EDT - Add to calendar
Aug 6, 2015
Q3 2015 Becton, Dickinson and Co Earnings Call - 8:00AM EDT - Add to calendar
Jun 10, 2015
Becton, Dickinson and Co at Goldman Sachs Healthcare Conference
Jun 1, 2015
Becton, Dickinson and Co at Jefferies Global Healthcare Conference
May 13, 2015
Becton, Dickinson and Co at Bank of America Merrill Lynch Health Care Conference
May 7, 2015
Q2 2015 Becton Dickinson and Co Earnings Release
May 7, 2015
Q2 2015 Becton, Dickinson and Co Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 10.53% 14.03%
Operating margin 14.29% 19.01%
EBITD margin - 25.67%
Return on average assets 3.70% 9.64%
Return on average equity 14.17% 23.47%
Employees 30,619 -
CDP Score - 92 B


One Becton Dr
United States - Map
+1-201-8476800 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Becton Dickinson and Co. is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The BD Medical segment manufactures syringes, needles and other products used in a range of healthcare settings. The BD Diagnostics segment collects and transport diagnostics specimens. The BD Biosciences segment produces clinical research tools that aid discovery and development of new drugs and vaccines.

Officers and directors

Vincent A. Forlenza Chairman of the Board, President, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Christopher R. Reidy Chief Financial Officer, Executive Vice President - Administration
Age: 57
Bio & Compensation  - Reuters
Alexandre Conroy President, Europe, EMA and the Americas
Age: 51
Bio & Compensation  - Reuters
James Lim President, Greater Asia
Age: 50
Bio & Compensation  - Reuters
Thomas E. Polen Segment President — Medical
Age: 41
Bio & Compensation  - Reuters
Linda M. Tharby Segment President — Life Sciences
Age: 46
Bio & Compensation  - Reuters
William A. Kozy Chief Operating Officer, Executive Vice President
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gary M. Cohen Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nabil Shabshab Senior Vice President, Chief Marketing Officer
Age: 49
Bio & Compensation  - Reuters
Jeffrey S Sherman Senior Vice President, General Counsel
Age: 59
Bio & Compensation  - Reuters